ArticleNature communications2025

Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer.

Anaïs Perrichet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.